<!DOCTYPE HTML>
<!--
	Phantom by HTML5 UP
	html5up.net | @ajlkn
	Free for personal and commercial use under the CCA 3.0 license (html5up.net/license)
-->
<html>
	<head>
		<title>Antiracist Care</title>
		<meta charset="utf-8" />
		<meta name="viewport" content="width=device-width, initial-scale=1, user-scalable=no" />
		<link rel="stylesheet" href="assets/css/main.css" />
		<noscript><link rel="stylesheet" href="assets/css/noscript.css" /></noscript>
		<link rel="icon" href="images/steth-logo.svg">
	</head>
	<body class="is-preload">
		<!-- Wrapper -->
			<div id="wrapper">

				<!-- Header -->
					<header id="header">
						<div class="inner">

							<!-- Logo -->
							<a href="index.html" class="logo">
								<span class="symbol"><img src="images/steth-logo.svg" alt="" /></span><span class="title">Antiracist Care</span>
							</a>

							<!-- Nav -->
								<nav>
									<ul>
										<li><a href="#menu">Menu</a></li>
									</ul>
								</nav>

						</div>
					</header>

				<!-- Menu -->
				<nav id="menu">
					<h2>Menu</h2>
					<ul>
						<li><a href="index.html">Home</a></li>
						<li><a href="cardiology.html">Cardiology</a></li>
						<li><a href="pediatrics.html">Nephrology</a></li>
						<li><a href="nephrology.html">Nephrology</a></li>
						<li><a href="endocrinology.html">Endocrinology</a></li>
						<li><a href="neurology.html">Neurology</a></li>
						<li><a href="oncology.html">Oncology</a></li>
						<li><a href="pulmonology.html">Pulmonology</a></li>
						<li><a href="urology.html">Urology</a></li>
						<li><a href="anesthesiology.html">Anesthesiology</a></li>
						<li><a href="general.html">General</a></li>
					</ul>
				</nav>

				<!-- Main -->
					<div id="main">
						<div class="inner">
							<h1>Pediatrics</h1>

							<div class="row">
								<!-- Key Points & References -->
								<div class="col-6 col-12-medium">
									<h2>Overview</h2>
										<p> [Placeholder for general blurb on pediatrics... ] </p>
								</div>
								<!-- Description -->
								<div class="col-6 col-12-medium">
									<h2> Topics </h2>
									<div class="table-wrapper">
										<table class="alt">
											<thead>
												<tr>
													<th></th>
													<th></th>
												</tr>
											</thead>
											<tbody>
												<tr>
													<td><a href= "#HBILI"> Hyperbilirubinemia </a> </td>
												</tr>
												<tr>
													<td><a href= "#HBILI"> Topic 2 </a> </td>
												</tr>
											</tbody>
										</table>
									</div>
								</div>
							</div>

							<!-- Line Break -->
							<a id="HBILI"> <hr /> </a>

							<section>
							<h2> Hyperbilirubinemia </h2>

							<!-- Quotations -->
							<blockquote>
							<b> Authors: </b> Angela Y. Zhang (she/hers), MD, University of Washington </br>
							<b> Reviewers: </b> Name, pronouns, degree, institution/location
							</blockquote>
							<div class="row">
								<!-- Description -->
								<div class="col-6 col-12-medium">
										<h3>Topic & Clinical Relevance</h3>
										<ul>
											<li>Hyperbilirubinemia refers to the buildup of bilirubin in the bloodstream. Bilirubin is a normal byproduct when our red blood cells break down at the end of their life cycle, and is passed through our liver and gut into feces. In babies, this system is immature and thus all babies have relatively higher bilirubin, which can show up as yellowed skin, or jaundice. For various reasons, the bilirubin may become higher than expected, and at very high levels can lead to brain damage. </li>
											<li>For this reason, it is routine to measure bilirubin in the newborn period, starting as early as at 24 hours of life. </li>
											<li>What clinical action is appropriate for a given level of bilirubin is determined by a few calculators - historically BiliTool, and more recently NCNC. <b> For a given bilirubin on BiliTool, East Asian race is cited as a risk factor that might prompt a provider to consider differential follow-up. </b> Of note, other risk factors are biologically reasonable, such as blood type incompatibility.  </li>
										</ul>
										<h3>Frequent Misconceptions</h3>

										<ul>
										  <li><b><em>Isn’t there a genetic association between East Asian race and hyperbilirubinemia?</b></em>
											<ul>
												<li>UpToDate's article "Unconjugated hyperbilirubinemia in the newborn: Pathogenesis and etiology" cites 2 papers for its claim that there is a common mutation in the UGT1A1 gene in Eastern Asian infants, which leads to an increased incidence of severe neonatal hyperbilirubinemia. However, these two papers consist of study populations with small N’s, as well as specific populations not generalizable to socially defined race.
												<ul>
													<li> <u>Reference 12:</u> A case-control study in Shenzen, China with n < 300 for both cases and controls, followed by a systematic review of the literature with most studies also having n < 200. Of note, the “Caucasian” population consists of only Turkish and American studies. (NB: Caucasian is no longer the preferred term given the eugenecist roots of the term) </li>
													<li> <u>Reference 13:</u> 42 Japanese newborns and 50 healthy German controls</li>
												</ul>
												</li>
											</ul>
											</li>
										  <li> <b><em>Doesn’t jaundice resolve at different time points in infants of different races? </b></em></li>
										    <ul>
										      <li>UpToDate cites a paper from Pediatrics to assert that visible jaundice resolves in different time frames in white, East Asian, and African-American infants.
														<ul>
															<li> <u> Reference 9:</u> Not only did the Pediatrics article in Reference 9 have a markedly skewed racial representation (figure), the paper states: “Our objective was to document the natural history of jaundice in the first month in a predominantly breastfed, white population of newborns, to identify the prevalence of prolonged hyperbilirubinemia and the clinical observation of jaundice in these infants, and to evaluate the utility of the cephalocaudal zone score as a screen for hyperbilirubinemia in office-based pediatric practice.” In other words, the paper’s aim was never to document racial differences and thus extrapolating as such even with significant results feels like an overreach. </li>
														</ul>
													</li>
											  </ul>
										  </li>
										</ul>

								</div>
								<!-- Key Points & References -->
								<div class="col-6 col-12-medium">
									<h3>How Adjustment Contributes to Health Inequity</h3>
									<ul>
										<li>Hyper-vigilance in East Asian infants for considering hyperbilirubinemia, thus possibly focusing care away from other groups</li>
									</ul>

									<h3>Possible Solutions</h3>
									<ul>
										<li> <b> Remove East Asian as a risk factor - in fact, the newer NCNC calculator does not mention race at all </b> and hopefully is being more widely adopted.</li>
										<li>Universal screening of bilirubin with a transcutaneous meter at 24 hours of life</li>
									</ul>
									<h3>Takeaway Points</h3>
									<ul>
										<li>While predisposition to hyperbilirubinemia may be genetically clustered, current data poorly define race, use small sample sizes, and extrapolate sub-ethnic groups to an entire socially defined category.</li>
										<li>Health equity is important to consider, only not in the form of this risk factor. Jaundice is harder to assess in darker skin, partially due to the lack of representation in medical school curriculum.</li>
									</ul>
									<h3>Sources</h3>
									<ol>
										<li><a href= "https://pubmed.ncbi.nlm.nih.gov/25049352/"> Maisels MJ, Clune S, Coleman K, Gendelman B, Kendall A, McManus S, Smyth M. The natural history of jaundice in predominantly breastfed infants. Pediatrics. 2014 Aug;134(2):e340-5. doi: 10.1542/peds.2013-4299. PMID: 25049352. [UpToDate Citation 9]</a></li>
										<li><a href= "https://pubmed.ncbi.nlm.nih.gov/9784835/"> Akaba K, Kimura T, Sasaki A, Tanabe S, Ikegami T, Hashimoto M, Umeda H, Yoshida H, Umetsu K, Chiba H, Yuasa I, Hayasaka K. Neonatal hyperbilirubinemia and mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene: a common missense mutation among Japanese, Koreans and Chinese. Biochem Mol Biol Int. 1998 Sep;46(1):21-6. doi: 10.1080/15216549800203512. PMID: 9784835. [UpToDate Citation 12]</a></li>
										<li><a href= "https://pubmed.ncbi.nlm.nih.gov/21272068/"> CLong J, Zhang S, Fang X, Luo Y, Liu J. Neonatal hyperbilirubinemia and Gly71Arg mutation of UGT1A1 gene: a Chinese case-control study followed by systematic review of existing evidence. Acta Paediatr. 2011 Jul;100(7):966-71. doi: 10.1111/j.1651-2227.2011.02176.x. Epub 2011 Feb 25. Erratum in: Acta Paediatr. 2012 Nov;101(11):1184. PMID: 21272068. [UpToDate Citation 13] </a></li>
									</ol>
								</div>
							</div>
						</section>




						</div>
					</div>

					<!-- Footer -->
						<footer id="footer">
							<div class="inner">
								<section>
									<h2>About</h2>

									<p> Our goal is to help organize and distill the ever-growing body of work on racism in medicine. We hope this project will be a resource to those advocating for antiracism in healthcare - from patients and providers to students, administrators, and policy makers who are pushing for change.</p>
									<p> If you have feedback or want to contribute content, please reach out! This is a work in progress. We’re always looking for new resources, perspectives, and thoughts on what makes people listen.</p>
									<!-- <form method="post" action="#">
										<div class="fields">
											<div class="field half">
												<input type="text" name="name" id="name" placeholder="Name" />
											</div>
											<div class="field half">
												<input type="email" name="email" id="email" placeholder="Email" />
											</div>
											<div class="field">
												<textarea name="message" id="message" placeholder="Message"></textarea>
											</div>
										</div>
										<ul class="actions">
											<li><input type="submit" value="Send" class="primary" /></li>
										</ul>
									</form> -->
								</section>
								<section>
									<h2>Contact</h2>

									<p><a href="https://mail.google.com/mail/?view=cm&source=mailto&to=antiracistcare@gmail.com">antiracistcare@gmail.com</a> </p>

									<!-- <ul class="icons">
										<li><a href="#" class="icon brands style2 fa-twitter"><span class="label">Twitter</span></a></li>
										<li><a href="#" class="icon brands style2 fa-facebook-f"><span class="label">Facebook</span></a></li>
										<li><a href="#" class="icon brands style2 fa-instagram"><span class="label">Instagram</span></a></li>
										<li><a href="#" class="icon brands style2 fa-dribbble"><span class="label">Dribbble</span></a></li>
										<li><a href="#" class="icon brands style2 fa-github"><span class="label">GitHub</span></a></li>
										<li><a href="#" class="icon brands style2 fa-500px"><span class="label">500px</span></a></li>
										<li><a href="#" class="icon solid style2 fa-phone"><span class="label">Phone</span></a></li>
										<li><a href="#" class="icon solid style2 fa-envelope"><span class="label">Email</span></a></li>
									</ul> -->
								</section>
								<ul class="copyright">
									<li>Antiracist Care, 2020</li> <li>Design: <a href="http://html5up.net">HTML5 UP</a></li>
								</ul>
							</div>
						</footer>

			</div>

		<!-- Scripts -->
			<script src="assets/js/jquery.min.js"></script>
			<script src="assets/js/browser.min.js"></script>
			<script src="assets/js/breakpoints.min.js"></script>
			<script src="assets/js/util.js"></script>
			<script src="assets/js/main.js"></script>

	</body>
</html>
